These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 26685282)
1. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment. Takayama K; Inoue S Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282 [TBL] [Abstract][Full Text] [Related]
2. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. Su YJ; Yu J; Huang YQ; Yang J Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379 [TBL] [Abstract][Full Text] [Related]
3. Deciphering the function of non-coding RNAs in prostate cancer. Ramalho-Carvalho J; Fromm B; Henrique R; Jerónimo C Cancer Metastasis Rev; 2016 Jun; 35(2):235-62. PubMed ID: 27221068 [TBL] [Abstract][Full Text] [Related]
4. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer. Ylipää A; Kivinummi K; Kohvakka A; Annala M; Latonen L; Scaravilli M; Kartasalo K; Leppänen SP; Karakurt S; Seppälä J; Yli-Harja O; Tammela TL; Zhang W; Visakorpi T; Nykter M Cancer Res; 2015 Oct; 75(19):4026-31. PubMed ID: 26282172 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA in prostate, bladder, and kidney cancer. Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs and prostate cancer. Misawa A; Takayama KI; Inoue S Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922 [TBL] [Abstract][Full Text] [Related]
8. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth. Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications. Xu YH; Deng JL; Wang G; Zhu YS Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841 [TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. Lin Y; Tan H; Yu G; Zhan M; Xu B Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674820 [TBL] [Abstract][Full Text] [Related]
12. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies]. Wang M; Ying J; Zhang M; Liang CZ Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs in prostate cancer: overview and clinical implications. Malik B; Feng FY Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'? Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411 [TBL] [Abstract][Full Text] [Related]
16. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136 [TBL] [Abstract][Full Text] [Related]
17. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target. Shiota M; Yokomizo A; Naito S J Mol Endocrinol; 2011 Aug; 47(1):R25-41. PubMed ID: 21504942 [TBL] [Abstract][Full Text] [Related]
18. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Takayama KI; Fujimura T; Suzuki Y; Inoue S Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143 [TBL] [Abstract][Full Text] [Related]
19. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism. Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121 [TBL] [Abstract][Full Text] [Related]
20. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]